MAM
AZN icon

Martingale Asset Management’s AstraZeneca AZN Stock Holding History

Martingale Asset Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-64,454
Closed -$3.83M – 875
2013
Q4 		$3.83M Buy
64,454
+1
+0% +$54 0.13% 203
2013
Q3 		$3.35M Buy
64,453
+1
+0% +$50 0.12% 207
2013
Q2 		$3.05M Buy
+64,452
New +$3.28M 0.11% 208

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
SCCM
Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Martingale Asset Management's AZN Position: Q1 2014 in Review

Martingale Asset Management sold out of AstraZeneca (AZN) in Q1 2014, closing a stake of 64,454 shares — an estimated $3.83M sold.

Martingale Asset Management first reported a position in AZN in Q2 2013 and held it in 3 quarters. The position peaked at $3.83M in Q4 2013. 388 funds tracked by Wall St. Rank hold AZN as of Q1 2014.

  • Martingale Asset Management reported no remaining AstraZeneca position as of Q1 2014 after selling out during the quarter.
  • Martingale Asset Management sold 64,454 AstraZeneca shares in Q1 2014, an estimated $3.83M.
  • Martingale Asset Management first reported a position in AstraZeneca in Q2 2013 and held it in 3 quarters.
  • Martingale Asset Management's AstraZeneca position peaked at $3.83M in Q4 2013.
  • 388 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2014.

Based on Martingale Asset Management's 13F filing for Q1 2014, filed 14 May 2014.